Abstract: A plug-in card for an optical transmission apparatus includes a J1 byte generating unit. The J1 byte generating unit sends information on on-use side J1 byte data to a plug-in card at a spare side in a redundant structure when the plug-in card operates as an on-use side plug-in card. The J1 byte generating unit receives information on on-use side J1 byte data from a plug-in card at the on-use side when the plug-in card operates as a spare side plug-in card. Based on the information, the J1 byte generating unit matches spare side J1 byte data to the on-use side J1 byte data. The plug-in card also includes a B3 byte calculating unit that operates in a similar way as the J1 byte generating unit does in processing B3 byte data.

Abstract: In order to increase the efficiency of large-capacity transmission, the continuity of divided signals generated by dividing a multiplexed signal is maintained and the original large-capacity multiplexed signal is restored. A signal dividing section divides a multiplexed signal to generate a plurality of divided signals in the STS or STM transmission interface format. A guarantee information adding section adds guarantee information for guaranteeing the continuity of the divided signals to each of the divided signals to generate transmission signals. A signal sending section sends the transmission signals via a transmission line in the transmission interface format. A signal receiving section receives the transmission signals. A signal restoring section restores the multiplexed signal by constructing the divided signals on the basis of the guarantee information.

Abstract: A process for production of a powder suitable for use in a process for the layer-by-layer moldless production of a three-dimensional shaped article, in which regions of the respective powder layer are selectively melted via input of electromagnetic energy, comprising mixing of a polymer or copolymer with at least one water-soluble polymeric polyol, the dissolution of the mixture in water to form a dispersion, the isolation of the polymer particles or copolymer particles from the dispersion, and the washing and drying of the isolated polymer particles or isolated copolymer particles; a powder which comprises a polymer powder or copolymer powder with from 0.001% by weight to 5% by weight content of at least one polymeric polyol, the polymeric polyol having been selected from the group consisting of polyethylene glycols and polyvinyl alcohols; the powder formed from the process; method of using the powder; and a shaped article formed from the powder.

Abstract: A heat resistant sheet containing inorganic fibers, wherein, among the inorganic fibers, a rate of a fiber(s) with a fiber length of about 200 ?m or less is about 40% or less, is provided.

Abstract: A read address from a memory and a write address to the memory are transmitted from a VT pointer circuit on an active side to a VT pointer circuit on a standby side in order to eliminate a difference between pointer values of the VT pointer circuits on the active and the standby sides, which is caused by a difference between the phases of the read address from the memory and the write address to the memory of the VT pointer circuits on the active and the standby sides, and the read and the write addresses on the standby side are overwritten with the transmitted address values. As a result, the address values can be made to match both on the active and the standby sides, and also the pointer values can be made to match.

Abstract: Three-dimensional shaped products are prepared by a layer-by-layer moldless production process in which at least one powder layer is provided, regions of the respective powder layer are selective melted via input of electromagnetic energy, wherein the powder of the powder layer contains at least one polymer powder or copolymer powder produced from a dispersion which contains at least one polymer or copolymer and which contains a water-soluble component, the water-soluble component containing at least one oligosaccharide.

Abstract: In order to increase the efficiency of large-capacity transmission, the continuity of divided signals generated by dividing a multiplexed signal is maintained and the original large-capacity multiplexed signal is restored. A signal dividing section divides a multiplexed signal to generate a plurality of divided signals in the STS or STM transmission interface format. A guarantee information adding section adds guarantee information for guaranteeing the continuity of the divided signals to each of the divided signals to generate transmission signals. A signal sending section sends the transmission signals via a transmission line in the transmission interface format. A signal receiving section receives the transmission signals. A signal restoring section restores the multiplexed signal by constructing the divided signals on the basis of the guarantee information.

Abstract: The present invention aims to solve the conventional problems by providing a peptide compound, in which when administered to a patient of immunologic disease, cardiac hypertrophy or a disease caused by NFAT activation, the period from administration to actual exhibition of effectiveness is short and there are no side effects or antigenicity. Specifically, the present invention relates to a membrane permeable NFAT inhibitory peptide comprising several consecutive arginines and a NFAT-activity inhibitory peptide sequence; a NFAT activation inhibitory agent comprising the peptide; and a immunosuppressive agent and cardiac hypertrophy suppressive agent, comprising the peptide compound as the active ingredient.

Abstract: The object of the present invention is to provide a suppressant for neuronal cell death effective for various diseases which inhibits a constitutive active forming of calcineurin and has less side effect. An inhibitor of constitutive active forming of calcineurin, more specifically a drug which inhibits cleavage of calcineurin subunit A (CaNA) by calpain. Examples thereof include peptides having the amino acid sequence of FDGATAAARKEVIRNK (SEQ No. 1) and REESESVLTLKGLTPTG (SEQ No. 2).

Abstract: The present invention aims to solve the conventional problems by providing a peptide compound, in which when administered to a patient of immunologic disease, cardiac hypertrophy or a disease caused by NFAT activation, the period from administration to actual exhibition of effectiveness is short and there are no side effects or antigenicity. Specifically, the present invention relates to a membrane permeable NFAT inhibitory peptide comprising several consecutive arginines and a NFAT-activity inhibitory peptide sequence; a NFAT activation inhibitory agent comprising the peptide; and a immunosuppressive agent and cardiac hypertrophy suppressive agent, comprising the peptide compound as the active ingredient.

Abstract: Noise information is acquired by a noise detecting microphone 2, speed information is acquired by a speed sensor 1 etc, and these items of information are inputted to a microcomputer 7. The microcomputer 7 reads a program 13 stored in a memory 8, and calculates a final correction quantity according to an instruction of the program 13. The microcomputer 7 judges whether to apply a correction quantity based on the noise information or the correction quantity based on the speed information or to increment and decrement these two types of correction quantities. Accordingly, an optimal played-back volume corresponding to a traveling condition can be outputted.

Abstract: The screening method for a compound or a salt thereof that alters the binding property between Neuromedin U or a salt thereof and TGR-1 or a salt thereof, characterized by using Neuromedin U, a derivative thereof or a salt thereof and TGR-1 or a salt thereof, can be useful for screening a therapeutic and/or prophylactic agent for hypertension and stress-related diseases, etc. A TGR-1 antagonist can be useful as a therapeutic and/or prophylactic agent for hypertension and stress-related diseases, etc.

Abstract: The present invention was developed in order to realize a multi-channel sound system wherein appropriate output (balance and fader) control can be conducted without adversely affecting the program contents, and a sound system, which can reproduce a plurality of channel signals including at least left and right front channels and a center channel for forward-placed speakers, comprises a gain controller to control the gain of either left or right channel signal and a gain controller to control the gain of the center channel signal depending on the gain control of the left or right channel signal.

Abstract: The object of the present invention is to provide a suppressant for neuronal cell death effective for various diseases which inhibits a constitutive active forming of calcineurin and has less side effect. An inhibitor of constitutive active forming of calcineurin, more specifically a drug which inhibits cleavage of calcineurin subunit A (CaNA) by calpain. Examples thereof include peptides having the amino acid sequence of FDGATAAARKEVIRNK (SEQ No. 1) and REESESVLTLKGLTPTG (SEQ No. 2).

Abstract: The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof. An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, an appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.

Abstract: A protein, a polynucleotide, an antibody of the present invention, etc. are useful as, for example, a diagnostic marker for a neurodegenerative disease and so on. A compound promoting or inhibiting the activity of the protein, a compound promoting or inhibiting the expression of a gene for the above protein, etc., which are obtained by a screening method with the use of the protein, polynucleotide or antibody as described above, are usable as, for example, a prophylactic/therapeutic agent for a neurodegenerative disease and so on.

Abstract: The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof. An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, a appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.

Abstract: The stretch tape of the present invention for eyelid facelifting is stuck in between eyes and near both inner corners of eyes, or beside and near the outer corner of each eye, enabling facelifting which makes the eyes look slitter and brighter by stretching the skins of eyelids by the stretch tape. Said stretch tape is tapered so that said stretch tape points the inner edge or the outer edge of the eye. The stretch tape of the present invention for nose facelifting has a shape of an inverted character U or an inverted character V, the top portion of the inverted character U or the inverted character V is stuck to an upper portion of the nose in between eyes, and both foot portions of the inverted character U or the inverted character V are stuck at both sides of the hillside portion of the nose, so that the stretch tape stretches the hillside portion of the nose toward a head.

Abstract: A compound or its salts inhibiting the activity of the protein of the present invention, a compound inhibiting the expression of a gene for the protein, the antisense polynucleotide of the present invention, the antibody of the present invention, and the like can be used as prophylactic/therapeutic agents for neurodegenerative disease, diabetes and the like. A compound or its salts promoting the activity of the protein of the present invention, a compound promoting the expression of a gene for the protein, etc. can be used as prophylactic/therapeutic agents for cancer, rheumatic disease, etc.

Abstract: Proposed is an optical clock distribution system in the WDM network, which particularly relates to a system to control clock synchronization between optical transmission devices constituting an optical communication network. The optical clock distribution system includes an optical clock generator converting a clock signal of PRC (Primary Reference Clock) level into an optical clock signal having a wavelength ?0; a wavelength multiplexer wavelength-multiplexing the optical clock signal having wavelength ?0 together with other optical wavelength data; and a wavelength-demultiplexer provided in a unit of the network, wavelength-demultiplexing the optical clock signal having wavelength ?0, wherein the other optical wavelength data are processed in the unit of the network using the wavelength-demultiplexed optical clock signal having wavelength ?0 as a reference clock.